Drug reviewers to hit the books

FDA reviewers can look forward to a break in their daily routine for education on advanced pharmaceutical manufacturing and technology.

Under a $652,000 contract just awarded by the regulator, the National Institute for Pharmaceutical Technology and Education (NIPTE) and Duquesne University will collaborate to develop educational content for the FDA Office of Pharmaceutical Science. OPS staff includes those who review and evaluate the quality-related information for new drug applications.

NIPTE will work with the OPS to identify education needs and then make recommendations on training areas. The educators will develop and deliver the content and assess its effectiveness in helping students with their review, research and policy-making activities. 

The  program is expected to run through September 2011.

- see the NIPTE announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.